Inhalation device
Latest Glaxo Group Limited Patents:
- Method of producing a recombinant protein
- Antigen binding proteins
- Pharmaceutical formulations comprising 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl) phenol
- Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
- Compounds
Description
FIG. 1 is a perspective view of an inhalation device showing our new design, with the cover shown in open position;
FIG. 2 is a side view thereof;
FIG. 3 is a front view thereof;
FIG. 4 is a back view thereof;
FIG. 5 is a top view thereof;
FIG. 6 is a bottom view thereof;
FIG. 7 is a perspective view thereof, with the cover shown in closed position;
FIG. 8 is a side view thereof;
FIG. 9 is a front view thereof;
FIG. 10 is a back view thereof;
FIG. 11 is a top view thereof; and,
FIG. 12 is a bottom view thereof.
Claims
The ornamental design for an inhalation device, as shown and described.
Referenced Cited
Patent History
Patent number: D495414
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Aug 31, 2004
Assignee: Glaxo Group Limited (Greenford)
Inventors: Michael L. King (Durham, NC), Alan Ball (Somerville, MA), James Taylor Lloyd (Somerville, MA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Robert J. Smith
Application Number: 29/172,923
Type: Grant
Filed: Dec 18, 2002
Date of Patent: Aug 31, 2004
Assignee: Glaxo Group Limited (Greenford)
Inventors: Michael L. King (Durham, NC), Alan Ball (Somerville, MA), James Taylor Lloyd (Somerville, MA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Robert J. Smith
Application Number: 29/172,923
Classifications
Current U.S. Class:
Respirator, Vaporizer, Or Inhalation Tube (4) (D24/110)
International Classification: 2902;
International Classification: 2902;